Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.

The Journal of biological chemistry·1999

Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.

Journal of immunology (Baltimore, Md. : 1950)·1999

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant.

Blood·1998

Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells.

European cytokine network·1998

Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.

Journal of immunology (Baltimore, Md. : 1950)·1998

Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.

Cytokine·1998

Bone marrow transplantation: current status.

Pathobiology annual·1982

Biology of cardiac overload.

Pathobiology annual·1982

Parathyroid hormone: chemistry and structure-activity relations.

Pathobiology annual·1981

Tamm-Horsfall uromucoprotein and the pathogenesis of casts, reflux nephropathy, and nephritides.

Pathobiology annual·1981

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Cancer management and research·2026

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

The Journal of steroid biochemistry and molecular biology·2026

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Tissue & cell·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Related Experiment Videos

Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity

Related Concept Videos

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.

Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant.

Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells.

Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.

Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.

Bone marrow transplantation: current status.

Biology of cardiac overload.

Parathyroid hormone: chemistry and structure-activity relations.

Tamm-Horsfall uromucoprotein and the pathogenesis of casts, reflux nephropathy, and nephritides.

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Related Experiment Videos

Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity

Related Concept Videos

Related Articles